SBI Securities’s SpringWorks Therapeutics SWTX Stock Holding History

SBI Securities’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-430	Closed	-$20.2K	–	4311
2025 Q2	$20.2K	Hold	430	–	–	﹤0.01%	1407
2025 Q1	$19K	Hold	430	–	–	﹤0.01%	1350
2024 Q4	$15.5K	Buy	+430	New	+$15K	﹤0.01%	1456

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

SBI Securities's SWTX Position: Q3 2025 in Review

SBI Securities sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 430 shares — an estimated $20.2K sold.

SBI Securities first reported a position in SWTX in Q4 2024 and held it in 3 quarters. The position peaked at $20.2K in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

SBI Securities reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
SBI Securities sold 430 SpringWorks Therapeutics shares in Q3 2025, an estimated $20.2K.
SBI Securities first reported a position in SpringWorks Therapeutics in Q4 2024 and held it in 3 quarters.
SBI Securities's SpringWorks Therapeutics position peaked at $20.2K in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on SBI Securities's 13F filing for Q3 2025, filed 5 Nov 2025.